SCHEMBL12436620

SCHEMBL12436620

CC1=C(C#N)C(=O)N(C)C(=O)/C1=C/c1ccc(-c2ccc(C(=O)O)cc2)o1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.59
NEK6 Q9HC98 1/20 0.53
POLB P06746 3/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
DNMT1 P26358 1/20 0.51
GFER P55789 1/20 0.51
CTDSP1 Q9GZU7 1/20 0.51
BRAF P15056 3/20 0.50
PSMB8 P28062 1/20 0.49
SIRT5 Q9NXA8 1/20 0.48
KDM4E B2RXH2 4/20 0.48
MAPT P10636 3/20 0.48
KLKB1 P03952 2/20 0.48
CTSB P07858 2/20 0.48
ELANE P08246 1/20 0.48
CTRB1 P17538 1/20 0.48
ALDH1A1 P00352 1/20 0.48
HTT P42858 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12436077 0.89 MEN1 (0.51) ESR2POLBL3MBTL1MEN1KMT2A
SCHEMBL14680238 0.89 ESR2 (0.61) ESR2NEK6POLBL3MBTL1MEN1
SCHEMBL18598255 0.86 ESR2 (0.58) ESR2NEK6POLBL3MBTL1MEN1
SCHEMBL6392502 0.78 BRAF (0.64) POLBL3MBTL1MEN1KMT2ADNMT1
SCHEMBL14584255 0.77 SIRT2 (0.52) ESR2NEK6POLBL3MBTL1MEN1
SCHEMBL8290667 0.77 ESR2 (0.55) ESR2NEK6POLBL3MBTL1MEN1
SCHEMBL8290540 0.76 SIRT2 (0.51) ESR2NEK6POLBL3MBTL1MEN1
SCHEMBL14680186 0.76 ESR2 (0.54) ESR2NEK6POLBL3MBTL1MEN1
SCHEMBL12435517 0.75 ESR2 (0.55) ESR2NEK6POLBL3MBTL1MEN1
SCHEMBL8291187 0.75 ESR2 (0.49) ESR2NEK6POLBL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011094708-A2 SMALL MOLECULES FOR THE MODULATION OF MCL-1 AND METHODS OF MODULATIING CELL DEATH, CELL DIVISION, CELL DIFFERENTIATION AND METHODS OF TREATING DISORDERS DANA-FARBER CANCER INSTITUTE, INC (US) 2011-08-04 WO disclosed